The influence of dopamine on prolactin cells
Warchoł, J.; Warchoł, T.
Acta Medica Polona 20(4): 467-468
1979
ISSN/ISBN: 0001-608X PMID: 546121 Document Number: 152136
Document emailed within 1 workday
Related Documents
Warchoł, J.B.; Zabel, M.; Warchoł, T. 1979: The influence of dopamine on coated vesicles in prolactin cells Acta Medica Polona 20(4): 463-466Rosa, A.A.; Djiane, J.; Houdebine, L.M.; Kelly, P.A. 1982: Stimulatory effects of prolactin and anti-prolactin receptor serum on prolactin binding sites in rat liver cells in suspension culture Biochemical and Biophysical Research Communications 106(1): 243-249
Oliveira, M.C.; Moraes, J.T.; Barros, H.M.; Barbosa-Coutinho, L.M. 1996: Effect of estrogen and neuroleptics on prolactin secretion and immunoreactive prolactin cells Brazilian Journal of Medical and Biological Research 29(4): 521-525
Jalalah, S.; Kovacs, K.; Horvath, E. 1988: Ultrastructural morphology of nontumorous prolactin cells in human pituitaries harboring prolactin-producing adenoma Journal of Submicroscopic Cytology and Pathology 20(2): 277-285
Lim, J.-h.; Kim, T.-y.; Kim, W.-h.; Park, J.-w. 2011: CAML promotes prolactin-dependent proliferation of breast cancer cells by facilitating prolactin receptor signaling pathways Breast Cancer Research and Treatment 130(1): 19-27
Lembowicz, K. 1971: Studies on prolactin-producing cells in rat pituitary gland during lactation using immunofluorescence technics. I. Effect of suckling on prolactin release rate Acta Physiologica Polonica 22(1): 83-90
Jimerson, D.C.; Post, R.M.; Skyler, J.; Bunney, W.E. 1976: Prolactin in cerebrospinal fluid and dopamine function in man Journal of Pharmacy and Pharmacology 28(11): 845-846
Andersen, A.N. 1977: Bromocriptine (Parlodel). a prolactin inhibiting dopamine receptor agonist Ugeskrift for Laeger 139(22): 1311-1313
Frawley, L.S.; Neill, J.D. 1984: Brief decreases in dopamine result in surges of prolactin secretion in monkeys American Journal of Physiology 247(6 Pt 1): E778-E780
Annunziato, L.; Quattrone, A.; Schettini, G.; Di Renzo, G. 1980: Supersensitivity of pituitary dopamine receptors involved in the inhibition of prolactin secretion Advances in Biochemical Psychopharmacology 24: 379-385
Onclin, K.; Silva, L.D.; Donnay, I.; Verstegen, J.P. 1993: Luteotrophic action of prolactin in dogs and the effects of a dopamine agonist, cabergoline Journal of Reproduction and Fertility. Supplement 47: 403-409
Valueva, G.V.; Iakovlev, A.A. 1987: Role of the renin-angiotensin system and prolactin in dopamine-induced secretion of aldosterone Vestnik Akademii Meditsinskikh Nauk SSSR 12: 61-65
Balabolkin, M.I.; Gerasimov, G.A.; Gubernatorov, E.E.; Kizyma, L.A. 1991: Role of enzymes of dopamine metabolism in the regulation of prolactin and thyrotropin secretion in hyperprolactinemia Problemy Endokrinologii 37(3): 26-28
Kerr, D.J.; Singh, V.K.; Alexander, W.D.; Sothern, R.B.; Halberg, F. 1986: Chronobiologic quantification of nocturnal low-dose dopamine effect on circadian rhythms of thyroid-related hormones and prolactin (PRL) Chronobiologia 13(3): 245-248
Michael Fahie-Wilson; Bieglmayer, C.; Jürgen Kratzsch; Nusbaumer, C.; Heinz Jürgen Roth; Zaninotto, M.; Plebani, M.; Hubbuch, A.; Schneider, E. 2007: Roche Elecsys Prolactin II assay: Reactivity with Macroprolactin Compared with Eight Commercial Assays for Prolactin and Determination of Monomeric Prolactin by Precipitation with Polyethylene Glycol Clinical Laboratory 53(5-6): 301-307
Maeda, T.; Sawada, K.; Itoh, Y.; Moriwaki, K.; Mori, H. 1991: Decreased prolactin level in secretory granules and their increased exocytosis in estrogen-induced pituitary hyperplasia in rats treated with a dopamine agonist Laboratory Investigation; a Journal of Technical Methods and Pathology 65(6): 679-687
Ferrari, C.; Romussi, M.; Benco, R.; Rampini, P.; Mailland, F. 1983: Effect of dihydroergocristine administration on serum prolactin and growth hormone levels in normal, hyperprolactinaemic, and acromegalic subjects: further evidence for pituitary dopamine deficiency in these conditions Acta Endocrinologica 103(1): 1-6
Van den Berghe, G.; de Zegher, F.; Vlasselaers, D.; Schetz, M.; Verwaest, C.; Ferdinande, P.; Lauwers, P. 1996: Thyrotropin-releasing hormone in critical illness: from a dopamine-dependent test to a strategy for increasing low serum triiodothyronine, prolactin, and growth hormone concentrations Critical Care Medicine 24(4): 590-595
Shintani, A.; Nakao, N.; Kakishita, K.; Itakura, T. 2007: Bone marrow stromal cell-mediated enhancement in the survival of dopamine cells and neuronal differentiation from ES cells No Shinkei Geka. Neurological Surgery 35(6): 607-614
Bellanca, L.; Latteri, M.T.; Latteri, S.; Bajardi, G.; Cassano, T.; Latteri, M. 1984: Influence of L-5-hydroxytryptophan on the secretion of prolactin and on plasma levels of gonadotropins La Clinica Terapeutica 109(5): 429-432